<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04615637</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL20_0191</org_study_id>
    <secondary_id>2020-A00634-35</secondary_id>
    <nct_id>NCT04615637</nct_id>
  </id_info>
  <brief_title>Helium 4 Optically Pumped Magnetometers : a New Generation of Sensors for High Speed Functional Brain Imaging</brief_title>
  <acronym>NEW MEG</acronym>
  <official_title>Helium 4 Optically Pumped Magnetometers : a New Generation of Sensors for High Speed Functional Brain Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Our goal is to perform a first evaluation of the capabilities of a new generation of&#xD;
      non-invasive magnetoencephalography sensors (OPM He4) to record brain magnetic activities.&#xD;
      The investigator will record 1) normal subjects stimulated with visual, auditory, somesthesic&#xD;
      and motor stimuli and 2) epileptic patient. The investigator will compare the signal to noise&#xD;
      ratio of the normal or pathological activities between classical MEG sensors and our OPM He4&#xD;
      prototype.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 1, 2021</start_date>
  <completion_date type="Anticipated">July 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">July 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Signal to Noise Ratio of the recorded brain activities</measure>
    <time_frame>1 month</time_frame>
    <description>Volunteers: The signal to noise ratio of normal brain activity following a stimulus will be computed with respect to the pre-stimulus baseline -100ms to -10 ms.&#xD;
Epileptic patient: The signal to noise ratio of abnormal epileptic brain activity will be computed with respect to a 100 ms baseline not containing any abnormal activity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Signal to Noise Ratio of pre-frontal auditory activity</measure>
    <time_frame>one month</time_frame>
    <description>evaluate the capacities of MPO to record pre-frontal auditory activities which are not recorded by classical MEG. EEG will be the reference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Signal to Noise Ratio of high frequency epileptic activity</measure>
    <time_frame>one month.</time_frame>
    <description>evaluate the capacities of our MPO to record high frequency epileptic signal which are not recorded by current generation of MPO</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort of the subject during the MPO He4 recordings for epileptic patient through a short verbal questionary</measure>
    <time_frame>5 minutes after the end the recording session</time_frame>
    <description>The evaluation will be done verbally through a short questionary. This questionary evaluates the overall comfort of the MPO system with two questions: 1) An evaluation of the overall comfort thanks to a scale with five steps from very uncomfortable to very comfortable and 2) A comparison with the classical MEG system thanks to a 5 steps scale from much less comfortable than the classical MEG system to much more comfortable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comfort of the subject during the MPO He4 recordings for volunteers through a short verbal questionary</measure>
    <time_frame>5 minutes after the end of each recording session</time_frame>
    <description>The evaluation will be done verbally through a short questionary. This questionary evaluates the overall comfort of the MPO system with two questions: 1) An evaluation of the overall comfort thanks to a scale with five steps from very uncomfortable to very comfortable and 2) A comparison with the classical MEG system thanks to a 5 steps scale from much less comfortable than the classical MEG system to much more comfortable.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Normal Subject</condition>
  <condition>Patient With Pharmaco-resistant Epilepsy</condition>
  <arm_group>
    <arm_group_label>Sensors</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will follow the same experimental procedure: a recording using classical MEG followed by a recording in the same condition with the OPM He4 prototype.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MEG recordings</intervention_name>
    <description>Classical MEG recordings (patient at rest, normal subjects stimulated with visual, motor, somesthesic and auditory stimuli).&#xD;
MEG recordings with our OPM He4 prototype (patient at rest, normal subjects stimulated with visual, motor, somesthesic and auditory stimuli).</description>
    <arm_group_label>Sensors</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Volunteers:&#xD;
&#xD;
          -  Age 18+&#xD;
&#xD;
          -  Right handed&#xD;
&#xD;
          -  Medical insurance&#xD;
&#xD;
          -  Strongly motivated to participate to the study&#xD;
&#xD;
          -  Signed informed consent for the study&#xD;
&#xD;
          -  No previous neurology or psychiatric pathologies&#xD;
&#xD;
          -  No major cognitive deficit and able to understand the instructions&#xD;
&#xD;
        Patients:&#xD;
&#xD;
          -  Age 18+&#xD;
&#xD;
          -  Right handed&#xD;
&#xD;
          -  Medical insurance&#xD;
&#xD;
          -  Strongly motivated to participate to the study&#xD;
&#xD;
          -  Signed informed consent for the study&#xD;
&#xD;
          -  No previous neurology or psychiatric pathologies (except epilepsy)&#xD;
&#xD;
          -  Epilepsy evolving during at least two years&#xD;
&#xD;
          -  No major cognitive deficit and able to understand the instructions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Volunteers:&#xD;
&#xD;
          -  Age &lt; 18 years or &gt; 60&#xD;
&#xD;
               -  previous neurology or psychiatric pathologies&#xD;
&#xD;
               -  Child bearing women&#xD;
&#xD;
               -  Subject having one of the following mettalic parts :&#xD;
&#xD;
                    -  (pacemaker, implentable pump, neurosimulator, chochlear implant, auditory&#xD;
                       prothesis, mettalic prothesis, intracerebral clip, implantable defibrilator,&#xD;
                       any mettalic parts in the brain or upper part of the body,&#xD;
                       ventriculoperitoneal valve)&#xD;
&#xD;
                    -  Claustrophobia Woman with a positive pregnancy test during the inclusion.&#xD;
&#xD;
        Patients:&#xD;
&#xD;
        Age &lt; 18 years or &gt; 60&#xD;
&#xD;
          -  previous neurology or psychiatric pathologies except epilepsy&#xD;
&#xD;
          -  Child bearing women&#xD;
&#xD;
          -  Subject having one of the following mettalic parts :&#xD;
&#xD;
               -  (pacemaker, implentable pump, neurosimulator, chochlear implant, auditory&#xD;
                  prothesis, mettalic prothesis, intracerebral clip, implantable defibrilator, any&#xD;
                  mettalic parts in the brain or upper part of the body, ventriculoperitoneal&#xD;
                  valve)&#xD;
&#xD;
               -  Claustrophobia Woman with a positive pregnancy test during the inclusion.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien JUNG, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien JUNG, MD</last_name>
    <phone>04.72.35.79.00</phone>
    <email>julien.jung@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Denis SCHWARTZ, MD</last_name>
    <phone>04.72.13.89.61</phone>
    <email>denis.schwartz@inserm.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Julien JUNG, MD</last_name>
      <phone>04 72 35 79 00</phone>
      <email>julien.jung@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>July 8, 2020</study_first_submitted>
  <study_first_submitted_qc>November 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 4, 2020</study_first_posted>
  <last_update_submitted>February 15, 2021</last_update_submitted>
  <last_update_submitted_qc>February 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>MEG</keyword>
  <keyword>OPM</keyword>
  <keyword>epilepsy</keyword>
  <keyword>normal brain activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

